Psilocybin 25 mgs

DRUG2 trials

Sponsors

NYU Langone Health, Johns Hopkins University

Conditions

Advanced CancerHealthy Volunteers

Phase 1

Psilocybin Brain Stimulation and Imaging Pilot Study

CompletedNCT06835699

Johns Hopkins UniversityHealthy Volunteers

Start: 2025-04-18End: 2026-05-21Updated: 2026-08-07

Phase 2

Psilocybin Therapy in Advanced Cancer

RecruitingNCT05398484

NYU Langone HealthAdvanced Cancer

Start: 2023-05-24End: 2027-01-01Target: 200Updated: 2025-12-04

Related Papers

Psilocybin-induced neurocardiogenic syncope: a case report.

2026-05-28